等待开盘 07-03 09:30:00 美东时间
-0.410
-2.73%
今日重点评级关注:Chardan Capital:维持EyePoint"买入"评级,目标价从29美元升至65美元;康托·菲茨杰拉德:维持Hyperliquid Strategies"超配"评级,目标价从8美元升至18.4美元
07-02 18:41
今日重点评级关注:Evercore ISI集团:维持ProQR Therapeutics"跑赢大市"评级,目标价从5美元升至6美元;摩根士丹利:维持霍尼韦尔"标配"评级,目标价从245美元升至490美元
06-30 10:14
今日重点评级关注:杰富瑞:上调Tango Therapeutics评级至"买入",目标价从27美元升至60美元;Susquehanna:维持安森美半导体"积极"评级,目标价从120美元升至140美元
06-29 15:49
今日重点评级关注:Chardan Capital:维持Ocular Therapeutix"买入"评级,目标价从21美元升至23美元;Guggenheim:维持Amylyx Pharmaceuticals"买入"评级,目标价从30美元升至40美元
06-26 17:42
Citigroup analyst Benjamin Gerlinger maintains Flagstar Bank (NYSE:FLG) with a Buy and raises the price target from $17 to $18.
06-26 03:22
HICKSVILLE, N.Y., June 3, 2026 /PRNewswire/ -- Flagstar Bank, N.A. (NYSE: FLG) (the "Bank") will participate at the Morgan Stanley U.S. Financials Conference to be held on Wednesday, June 10...
06-03 20:30
Joseph Otting's Employment Agreement in His Role as CEO Extended Through March 2028Richard Raffetto and Lee Smith Named Co-Presidents and Co-Chief Operating Officers with Expanded ResponsibilitiesBao Nguyen Named Chief
05-19 04:31
华盛资讯5月8日讯,Flagstar Financial公布2026财年Q1业绩,公司Q1营收4.98亿美元,同比增长1.6%,归母净利润0.13亿美元,扭亏为盈。
05-08 10:52
今日重点评级关注:Canaccord Genuity:维持Intellia Therapeutics"买入"评级,目标价从48美元升至58美元;富国银行:维持曼恩凯德生物医疗"超配"评级,目标价从7美元升至8美元
04-29 10:28